A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant.

Kamilia Smith, MD, FACOG, NCMP, discusses how shared decision-making approaches combined with emerging neurokinin-targeted ...

It belongs to a class of drugs called neurokinin-1 (NK1) receptor antagonists. As a potent antiemetic, the medication works ...